Rare primary effusion lymphoma associated with HHV-8 in Japan

Intern Med. 2010;49(13):1303-6. doi: 10.2169/internalmedicine.49.3587. Epub 2010 Jul 1.

Abstract

We describe a 62-year-old man infected with human immunodeficiency virus (HIV)-1 who developed primary effusion lymphoma (PEL). Pleural effusion contained atypical lymphoid cells with human herpesvirus (HHV)-8 latent nuclear antigen (LANA)(+). Radiological examination revealed pleural and pericardial effusion, but no evidence of tumor mass or lymph node enlargement. The patient was administered with highly active anti retroviral therapy (HAART) and THP-COP therapy, resulting in complete remission. The prevalence of HHV-8 infection among HIV positive individuals is higher than in the general population in Japan. Although PEL is extremely rare in Japan, the incidence might increase in the future.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Doxorubicin / analogs & derivatives
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Herpesviridae Infections / complications*
  • Herpesviridae Infections / drug therapy
  • Herpesvirus 8, Human*
  • Humans
  • Japan
  • Lymphoma, Primary Effusion / diagnosis*
  • Lymphoma, Primary Effusion / drug therapy
  • Lymphoma, Primary Effusion / virology*
  • Male
  • Middle Aged
  • Prednisolone / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • VEP-THP protocol